Blood Testing for Organ Injury from Covid-19
Researchers have developed a blood test that uses cell-free DNA to gauge the damage that covid-19 inflicts on cells, tissues, and organs, and could help aid in the development of new therapies.
Read MorePosted by Laurie Bonner | Feb 5, 2021 | Covid 19, Molecular Diagnostics |
Researchers have developed a blood test that uses cell-free DNA to gauge the damage that covid-19 inflicts on cells, tissues, and organs, and could help aid in the development of new therapies.
Read MorePosted by Melanie Hamilton-Basich | Feb 2, 2021 | Allergy & Autoimmune, Infectious Diseases, Sexually Transmitted Diseases, Standards |
ATCC joins the National Institute of Allergy and Infectious Diseases’ team working on preclinical services for HIV therapeutics.
Read MorePosted by Melanie Hamilton-Basich | Feb 1, 2021 | Covid 19 |
Together, the Detectr Boost SARS-CoV-2 Kit and Agilent automated liquid handling system would provide a complete workflow for high-throughput covid-19 testing.
Read MorePosted by Melanie Hamilton-Basich | Jan 29, 2021 | Lab Automation |
The new semi-automated workflow is designed to increase yield, sensitivity, and throughput by delivering exponentially more target cfDNA and ctDNA for molecular assays with greater automation and reduced hands-on technician time.
Read MorePosted by Laurie Bonner | Jan 21, 2021 | Covid 19, Molecular Diagnostic Analyzers |
Droplet digital PCR can detect covid-19 cases qPCR misses.
Read More